Heterogeneity of Breast Cancer among Patients and Implications for Patient Selection for Adjuvant Chemotherapy

By Andre Fabrice   Pusztai Lajos  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1951-1958

Springer Publishing Company

Access to resources Recommend Favorite

Improved QOL with capecitabine in breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

QOL benefits with palliative chemotherapy in ovarian cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Colorectal cancer staging and adjuvant chemotherapy

By Gelmann A.   Desnoyers R.   Cagir B.   Weinberg D.   Boman B.M.   Waldman S.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 737-755

Informa Healthcare

Access to resources Recommend Favorite

Effect of Creatinine Clearance on Patterns of Toxicity in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer

By Hurria Arti   Hurria Anju   Brogan Kelly   Panageas Katherine S.   Pearce Carol   Norton Larry   Jakubowski Ann   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. : 785-791

Adis International

Access to resources Recommend Favorite